Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care setting

  • L. Ostrosky-Zeichner
  • C. Sable
  • J. Sobel
  • B. D. Alexander
  • G. Donowitz
  • V. Kan
  • C. A. Kauffman
  • D. Kett
  • R. A. Larsen
  • V. Morrison
  • M. Nucci
  • P. G. Pappas
  • M. E. Bradley
  • S. Major
  • L. Zimmer
  • D. Wallace
  • W. E. Dismukes
  • J. H. Rex
Concise Article

Abstract

The study presented here was performed in order to create a rule that identifies subjects at high risk for invasive candidiasis in the intensive care setting. Retrospective review and statistical modelling were carried out on 2,890 patients who stayed at least 4 days in nine hospitals in the USA and Brazil; the overall incidence of invasive candidiasis in this group was 3% (88 cases). The best performing rule was as follows: Any systemic antibiotic (days 1–3) OR presence of a central venous catheter (days 1–3) AND at least TWO of the following—total parenteral nutrition (days 1–3), any dialysis (days 1–3), any major surgery (days −7–0), pancreatitis (days −7–0), any use of steroids (days −7–3), or use of other immunosuppressive agents (days −7–0). The rate of invasive candidiasis among patients meeting the rule was 9.9%, capturing 34% of cases in the units, with the following performance: relative risk 4.36, sensitivity 0.34, specificity 0.90, positive predictive value 0.01, and negative predictive value 0.97. The rule may identify patients at high risk of invasive candidiasis.

References

  1. 1.
    Gudlaugsson O, Gillespie S, Lee K, Vande Berg J, Hu J, Messer S, Herwaldt L, Pfaller M, Diekema D (2003) Attributable mortality of nosocomial scandidemia, revisited. Clin Infect Dis 37:1172–1177PubMedCrossRefGoogle Scholar
  2. 2.
    Rentz AM, Halpern MT, Bowden R (1998) The impact of candidemia on length of hospital stay, outcome, and overall cost of illness. Clin Infect Dis 27:781–788PubMedGoogle Scholar
  3. 3.
    Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB (2004) Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 39:309–317PubMedCrossRefGoogle Scholar
  4. 4.
    Eggimann P, Francioli P, Bille J, Schneider R, Wu MM, Chapuis G, Chiolero R, Pannatier A, Schilling J, Geroulanos S, Glauser MP, Calandra T (1999) Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients. Crit Care Med 27:1066–1072PubMedCrossRefGoogle Scholar
  5. 5.
    Garbino J, Lew DP, Romand JA, Hugonnet S, Auckenthaler R, Pittet D (2002) Prevention of severe Candida infections in nonneutropenic, high-risk, critically ill patients: a randomized, double-blind, placebo-controlled trial in patients treated by selective digestive decontamination. Intensive Care Med 28:1708–1717PubMedCrossRefGoogle Scholar
  6. 6.
    Pelz RK, Hendrix CW, Swoboda SM, Diener-West M, Merz WG, Hammond J, Lipsett PA (2001) Double-blind placebo-controlled trial of fluconazole to prevent candidal infections in critically ill surgical patients. Ann Surg 233:542–548PubMedCrossRefGoogle Scholar
  7. 7.
    Blumberg HM, Jarvis WR, Soucie JM, Edwards JE, Patterson JE, Pfaller MA, Rangel-Frausto MS, Rinaldi MG, Saiman L, Wiblin RT, Wenzel RP (2001) Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. The National epidemiology of mycosis survey. Clin Infect Dis 33:177–186PubMedCrossRefGoogle Scholar
  8. 8.
    Rex JH, Sobel JD (2001) Prophylactic antifungal therapy in the intensive care unit. Clin Infect Dis 32:1191–1200PubMedCrossRefGoogle Scholar
  9. 9.
    Pittet D, Monod M, Suter PM, Frenk E, Auckenthaler R (1994) Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg 220:751–758PubMedCrossRefGoogle Scholar
  10. 10.
    Piarroux R, Grenouillet F, Balvay P, Tran V, Blasco G, Millon L, Boillot A (2004) Assessment of Pre-emptive treatment to prevent severe candidiasis in critically ill surgical patients. Crit Care Med 32:2443–2449PubMedCrossRefGoogle Scholar
  11. 11.
    Leon C, Ruiz-Santana S, Saavedra P, Almirante B, Nolla-Salas J, Alvarez-Lerma F, Garnacho-Montero J, Leon MA (2006) A bedside scoring system (“Candida score”) for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization. Crit Care Med 34:730–737PubMedCrossRefGoogle Scholar
  12. 12.
    Ascioglu S, Rex JH, de Pauw B, Bennett JE, Bille J, Crokaert F, Denning DW, Donnelly JP, Edwards JE, Erjavec Z, Fiere D, Lortholary O, Maertens J, Meis JF, Patterson TF, Ritter J, Selleslag D, Shah PM, Stevens DA, Walsh TJ (2002) Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 34:7–14PubMedCrossRefGoogle Scholar
  13. 13.
    Paphitou NI, Ostrosky-Zeichner L, Rex JH (2005) Rules for identifying patients at increased risk for candidal infections in the surgical intensive care unit: an approach to developing practical criteria for systematic use in antifungal prophylaxis trials. Med Mycol 43:235–243PubMedGoogle Scholar
  14. 14.
    Dupont H, Bourichon A, Paugam-Burtz C, Mantz J, Desmonts JM (2003) Can yeast isolation in peritoneal fluid be predicted in intensive care unit patients with peritonitis? Crit Care Med 31:752–757PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2007

Authors and Affiliations

  • L. Ostrosky-Zeichner
    • 1
  • C. Sable
    • 2
  • J. Sobel
    • 3
  • B. D. Alexander
    • 4
  • G. Donowitz
    • 5
  • V. Kan
    • 6
  • C. A. Kauffman
    • 7
  • D. Kett
    • 8
  • R. A. Larsen
    • 9
  • V. Morrison
    • 10
  • M. Nucci
    • 11
  • P. G. Pappas
    • 12
  • M. E. Bradley
    • 13
  • S. Major
    • 14
  • L. Zimmer
    • 14
  • D. Wallace
    • 14
  • W. E. Dismukes
    • 12
  • J. H. Rex
    • 15
  1. 1.University of Texas Health Science Center at HoustonHoustonUSA
  2. 2.Merck Research LaboratoriesBlue BellUSA
  3. 3.Wayne State UniversityDetroitUSA
  4. 4.Duke University Medical CenterDurhamUSA
  5. 5.University of Virginia Health SystemCharlottesvilleUSA
  6. 6.VA Medical CenterWashingtonUSA
  7. 7.University of Michigan Medical CenterAnn ArborUSA
  8. 8.Jackson Memorial HospitalMiamiUSA
  9. 9.Univeristy of Southern CaliforniaLos AngelesUSA
  10. 10.VA Medical CenterMinneapolisUSA
  11. 11.Hospital Universitário Clementino Fraga Filho Universidade Federal do Rio de Janeiro (UFRJ)Rio de JaneiroBrazil
  12. 12.University of Alabama at BirminghamBirminghamUSA
  13. 13.University of Alabama at BirminghamBirminghamUSA
  14. 14.RhoChapel HillUSA
  15. 15.AstraZeneca, Alderley HouseMacclesfieldUK

Personalised recommendations